Tuesday, Nov 24, 2020 | Last Update : 09:35 PM IST

  Business   Companies  13 Aug 2020  India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

REUTERS
Published : Aug 13, 2020, 11:01 am IST
Updated : Aug 13, 2020, 11:01 am IST

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

 Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)
  Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)

BENGALURU: Zydus Cadila on Thursday launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India to treat COVID-19 following reports of shortages at hospitals in the world’s third-worst hit nation.

Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients, the company said in a regulatory filing.

 

Officials in some Indian states had a few weeks ago complained of supply issues, but a top executive at drugmaker Cipla Ltd had earlier this week said the supplies were stabilising.

Zydus is the fifth company to launch a copy of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd.

Gilead has also entered into licensing agreements with Dr. Reddy’s Laboratories Ltd and Syngene International Ltd to make remdesivir for distribution in 127 countries, including India.

India has reported a daily jump of more than 50,000 coronavirus infections for two weeks, with total cases as of Wednesday at 2.33 million.

 

Tags: zydus cadila, gilead sciences, antiviral drug, remdesivir, india, covid-19
Location: India, Karnataka, Bengaluru